ArticleClinical and vaccine immunology : CVI2015

Development of a Recombinant Xenogeneic Tumor Necrosis Factor Alpha Protein Vaccine To Protect Mice from Experimental Colitis.

Yang Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.